In summary, we demonstrated that in women with PCOS, IR is the main risk factor for the development of NAFLD and that when interacting with the rs738409 PNPLA3 polymorphism, the effect is synergistic, contributing to an even higher risk of developing the disease. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.